What is the recommended management for a subconjunctival hemorrhage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Subconjunctival Hemorrhage

Subconjunctival hemorrhage is a benign, self-limited condition that requires no specific treatment in the vast majority of cases—reassurance and observation are sufficient.

Initial Assessment

The primary goal is to rule out serious underlying causes rather than treat the hemorrhage itself:

  • Obtain a thorough history focusing on trauma (including minor trauma like eye rubbing), anticoagulation use, recent coughing/vomiting/straining episodes, and bleeding disorders 1, 2
  • Examine for associated findings including visual acuity changes, pain, or signs of globe injury that would suggest more serious pathology 1
  • Check blood pressure as hypertension is a common risk factor, particularly in elderly patients 2, 3

Standard Management Approach

For uncomplicated subconjunctival hemorrhage:

  • No treatment is necessary—the hemorrhage will spontaneously resolve over 1-3 weeks as the blood is reabsorbed 1, 2
  • Reassure the patient about the benign nature and expected resolution timeline 1
  • Artificial tears may provide comfort if mild irritation is present, though this is supportive rather than therapeutic 1

When to Investigate Further

Recurrent or bilateral hemorrhages mandate workup for underlying systemic disease:

  • Two or more episodes warrant evaluation for blood dyscrasias, coagulopathy, uncontrolled hypertension, diabetes, or medication effects (particularly anticoagulants) 4, 2
  • Severe or recurrent cases should prompt assessment for conjunctivochalasis, which is significantly associated with recurrent subconjunctival hemorrhage—patients with ≥3 episodes show significantly higher grades of conjunctivochalasis (p=0.003) 5
  • Review medications including anticoagulants, antiplatelet agents, and NSAIDs that may predispose to bleeding 4, 2

Special Considerations

In pediatric patients (<3 years):

  • Subconjunctival hemorrhage is uncommon (prevalence 0.4%) and should not be attributed to uncomplicated cough, vomiting, or constipation 6
  • Trauma accounts for 83% of cases across all pediatric age groups, including infants 7
  • Carefully examine for other signs of trauma (ocular or non-ocular) as abuse must be considered in the differential diagnosis 6, 7

For recurrent cases with conjunctivochalasis:

  • Surgical treatment of conjunctivochalasis eliminates recurrences in >80% of patients and significantly reduces hemorrhage frequency (p<0.0001) 5
  • Consider this option for patients with frequent recurrences (≥3 episodes) and moderate-to-severe conjunctivochalasis 5

Follow-up

  • No routine follow-up is needed for isolated, uncomplicated cases 1
  • Return if the hemorrhage does not resolve within 2-3 weeks, vision changes occur, or pain develops 1
  • Schedule evaluation for recurrent cases to investigate underlying systemic causes 2

References

Research

Subconjunctival hemorrhage: overview and management.

Journal of the American Optometric Association, 1986

Research

Subconjunctival hemorrhage: risk factors and potential indicators.

Clinical ophthalmology (Auckland, N.Z.), 2013

Research

Subconjunctival hemorrhage after intravitreal injection of anti-vascular endothelial growth factor.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2015

Research

Subconjunctival and external hemorrhage secondary to oral anticoagulation.

Journal of the American Optometric Association, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.